CRYZL1 Human

Quinone Oxidoreductase-like Protein 1 Human Recombinant
Cat. No.
BT17719
Source
Escherichia Coli.
Synonyms
Quinone Oxidoreductase-like Protein 1, Quinone oxidoreductase homolog 1, Zeta-crystallin homolog, Protein 4P11, QOH-1, CRYZL1, 4P11.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CRYZL1 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 369 amino acids (1-349 a.a.) and having a molecular mass of 40.8 kDa. CRYZL1 is fused to a 20 amino acid His Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Quinone Oxidoreductase (CRYZL1), also known as zeta-crystallin-like protein 1, shares similarities with zeta crystalline in its amino acid sequence. Functioning as an NADPH-dependent quinone reductase, CRYZL1 is distinct from other known reductases of the same category. Its role potentially extends to acting as a pH response element-binding protein. CRYZL1 possesses an NAD(P)H binding site and is expressed in varying degrees across different tissues, including the heart, brain, skeletal muscle, kidney, pancreas, liver, and lung. Notably, it is found in low concentrations within human lens tissue.
Description
Recombinant CRYZL1, derived from humans and produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 369 amino acids, specifically spanning from amino acid positions 1 to 349. With a molecular weight of 40.8 kDa, the protein features a 20 amino acid His Tag fused at its N-terminus. Purification is achieved through proprietary chromatographic methods.
Physical Appearance
The product appears as a colorless solution that has been sterilized through filtration.
Formulation
The CRYZL1 solution is prepared with 20mM Tris-HCl buffer at a pH of 8.0. It also contains 2mM DTT, 0.1M NaCl, and 20% glycerol.
Stability
For optimal storage, keep the vial at 4°C if it will be fully utilized within 2-4 weeks. For extended storage periods, freeze at -20°C. To further enhance long-term preservation, adding a carrier protein like 0.1% HSA or BSA is recommended. Avoid subjecting the solution to repeated cycles of freezing and thawing.
Purity
The purity of CRYZL1 exceeds 95%, as determined by SDS-PAGE analysis.
Synonyms
Quinone Oxidoreductase-like Protein 1, Quinone oxidoreductase homolog 1, Zeta-crystallin homolog, Protein 4P11, QOH-1, CRYZL1, 4P11.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MKGLYFQQSS TDEEITFVFQ EKEDLPVTED NFVKLQVKAC ALSQINTKLL AEMKMKKDLF PVGREIAGIV LDVGSKVSFF QPDDEVVGIL PLDSEDPGLC EVVRVHEHYL VHKPEKVTWT EAAGSIRDGV RAYTALHYLS HLSPGKSVLI MDGASAFGTI AIQLAHHRGA KVISTACSLE DKQCLERFRP PIARVIDVSN GKVHVAESCL EETGGLGVDI VLDAGVRLYS KDDEPAVKLQ LLPHKHDIIT LLGVGGHWVT TEENLQLDPP DSHCLFLKGA TLAFLNDEVW NLSNVQQGKY LCILKDVMEK LSTGVFRPQL DEPIPLYEAK VSMEAVQKNQ GRKKQVVQF.

Product Science Overview

Gene and Protein Structure

The CRYZL1 gene is located on chromosome 13 in humans . The gene undergoes alternative splicing, resulting in multiple transcript variants, although the full-length nature of these variants has not been completely determined . The protein encoded by this gene is involved in various cellular processes, including the reduction of quinones to hydroquinones, which helps in detoxifying reactive quinones and preventing oxidative stress .

Enzymatic Function

Quinone oxidoreductase-like protein 1 functions as a two-electron reductase, catalyzing the reduction of quinones to hydroquinones . This reaction is essential for detoxifying quinones, which can generate reactive oxygen species (ROS) through redox cycling mechanisms . By reducing quinones to hydroquinones, CRYZL1 helps in preventing the formation of semiquinone free radicals and other harmful oxidative species .

Physiological Role

The physiological role of CRYZL1 extends beyond its enzymatic activity. It is involved in maintaining cellular redox balance and protecting cells from oxidative damage . The enzyme’s activity is crucial in tissues exposed to high levels of oxidative stress, such as the liver and lungs . Additionally, CRYZL1 plays a role in the metabolism of vitamin K, which is essential for blood clotting and bone health .

Clinical Significance

Mutations or alterations in the CRYZL1 gene can have significant clinical implications. For instance, certain polymorphic forms of the protein may be associated with an increased risk of developing various diseases, including cancer . The enzyme’s role in detoxifying reactive quinones and maintaining cellular redox balance makes it a potential target for therapeutic interventions in diseases characterized by oxidative stress and redox imbalance .

Recombinant Protein

The human recombinant form of Quinone Oxidoreductase-like Protein 1 is produced using recombinant DNA technology. This involves inserting the CRYZL1 gene into an expression vector, which is then introduced into a host cell (such as E. coli or yeast) to produce the protein . The recombinant protein is purified and used in various research applications, including studies on enzyme function, drug development, and disease mechanisms .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.